Oramed Pharmaceuticals (ORMP) Net Cash Flow Growth (3y) (2013 - 2026)
Oramed Pharmaceuticals (ORMP) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
-26.15% |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.15% |
| Dec 31, 2025 |
-41.54% |
| Sep 30, 2025 |
122.53% |
| Jun 30, 2025 |
-221.37% |
| Mar 31, 2025 |
236.81% |
| Nov 30, 2021 |
-241.86% |
| Aug 31, 2021 |
242.61% |
| May 31, 2021 |
296.78% |
| Feb 28, 2021 |
110.01% |
| Nov 30, 2020 |
-17.18% |
| May 31, 2020 |
129.24% |
| Feb 29, 2020 |
74.31% |
| Nov 30, 2019 |
53.95% |
| Aug 31, 2019 |
-44.94% |
| May 31, 2019 |
96.06% |
| Feb 28, 2019 |
-32.74% |
| Nov 30, 2018 |
3.52% |
| Aug 31, 2018 |
59.24% |
| May 31, 2018 |
-48.30% |
| Feb 28, 2018 |
33.27% |
